JAMP Pharma Corporation

jamppharma.com

JAMP Pharma is now the 4th Canadian pharmaceutical company in terms of portfolio of generic products. Since 2009, JAMP Pharma is a generic company the fastest growing in Canada.

C-Suite On Deck

Responsive image

Feature market insights and perspectives from top C-Level executives, elite technology influencers and thought leaders from your company here. This signature initiative has garnered immense support...

Contact Us

Events

Related News

Business Insights

GNS HEALTHCARE AND ARVINAS ENTER INTO NEUROSCIENCE DRUG DISCOVERY COLLABORATION

GNS Healthcare | May 10, 2022

news image

GNS Healthcare, the leader in the use of "Virtual Patients", Causal AI and simulation technology for biopharmaceutical companies, today announced a collaboration with Arvinas, Inc. (Nasdaq: ARVN), a clinical-stage biotechnology company creating a new class of drugs based on targeted protein degradation, to generate insights to help accelerate drug development for neurodegenerative diseases. Every year more than six million patients in the United States alone are diagnose...

Read More

Business Insights, VIEWS AND ANALYSIS

MIRION TECHNOLOGIES TO DIVEST BIODEX PHYSICAL MEDICINE

Biodex Medical Systems | November 30, 2022

news image

Mirion Technologies, Inc. announced that it has entered into a definitive agreement to sell the physical medicine assets of Biodex Medical Systems, Inc. to Salona Global Medical Device Corporation for $5 million in cash at closing and up to an additional $3 million in deferred cash payments. The deferred cash payments are contingent on the performance of the assets during the 12-month period following closing. The assets generated approximately $18 million in revenue with estimated gross margins...

Read More

Pharmacy Market

NANOTEMPER TECHNOLOGIES UNVEILS BIOTINYLATED TARGET LABELING KIT, EMPOWERING SCIENTISTS IN PHARMA INDUSTRY TO TACKLE CHALLENGING DRUG TARGETS

Businesswire | June 30, 2023

news image

NanoTemper Technologies, creator of biophysical tools for drug discovery, today, proudly announced the launch of their highly anticipated Biotinylated Target Labeling Kit, expanding the molecular interaction analysis toolkit for scientists working with complex or undruggable targets, filling a vital gap in screening and hit validation workflows in the pharma industry. This new kit combined with NanoTemper’s exclusive Spectral Shift technology is the preferred orthogonal me...

Read More

Pharma Tech

PORTON ADVANCED AND ROYALTECH ANNOUNCE STRATEGIC COLLABORATION TO ACCELERATE THE DEVELOPMENT OF BACTERIAL DRUGS AND MRNA DRUGS

Porton Advanced Solutions | August 29, 2022

news image

Porton Advanced Solutions.announced a strategic cooperation with Suzhou Royaltech Med Co., Ltd. This strategic collaboration will further integrate the resources and capabilities of both parties, jointly promote the establishment of microbial vectors used for gene therapy and mRNA drug platform technology, and accelerate the R&D process of bioinnovative drugs. Porton Advanced provides an end-to-end gene and cell therapy CDMO service platform covering plasmids, cell therapy, ge...

Read More
news image

Business Insights

GNS HEALTHCARE AND ARVINAS ENTER INTO NEUROSCIENCE DRUG DISCOVERY COLLABORATION

GNS Healthcare | May 10, 2022

GNS Healthcare, the leader in the use of "Virtual Patients", Causal AI and simulation technology for biopharmaceutical companies, today announced a collaboration with Arvinas, Inc. (Nasdaq: ARVN), a clinical-stage biotechnology company creating a new class of drugs based on targeted protein degradation, to generate insights to help accelerate drug development for neurodegenerative diseases. Every year more than six million patients in the United States alone are diagnose...

Read More
news image

Business Insights, VIEWS AND ANALYSIS

MIRION TECHNOLOGIES TO DIVEST BIODEX PHYSICAL MEDICINE

Biodex Medical Systems | November 30, 2022

Mirion Technologies, Inc. announced that it has entered into a definitive agreement to sell the physical medicine assets of Biodex Medical Systems, Inc. to Salona Global Medical Device Corporation for $5 million in cash at closing and up to an additional $3 million in deferred cash payments. The deferred cash payments are contingent on the performance of the assets during the 12-month period following closing. The assets generated approximately $18 million in revenue with estimated gross margins...

Read More
news image

Pharmacy Market

NANOTEMPER TECHNOLOGIES UNVEILS BIOTINYLATED TARGET LABELING KIT, EMPOWERING SCIENTISTS IN PHARMA INDUSTRY TO TACKLE CHALLENGING DRUG TARGETS

Businesswire | June 30, 2023

NanoTemper Technologies, creator of biophysical tools for drug discovery, today, proudly announced the launch of their highly anticipated Biotinylated Target Labeling Kit, expanding the molecular interaction analysis toolkit for scientists working with complex or undruggable targets, filling a vital gap in screening and hit validation workflows in the pharma industry. This new kit combined with NanoTemper’s exclusive Spectral Shift technology is the preferred orthogonal me...

Read More
news image

Pharma Tech

PORTON ADVANCED AND ROYALTECH ANNOUNCE STRATEGIC COLLABORATION TO ACCELERATE THE DEVELOPMENT OF BACTERIAL DRUGS AND MRNA DRUGS

Porton Advanced Solutions | August 29, 2022

Porton Advanced Solutions.announced a strategic cooperation with Suzhou Royaltech Med Co., Ltd. This strategic collaboration will further integrate the resources and capabilities of both parties, jointly promote the establishment of microbial vectors used for gene therapy and mRNA drug platform technology, and accelerate the R&D process of bioinnovative drugs. Porton Advanced provides an end-to-end gene and cell therapy CDMO service platform covering plasmids, cell therapy, ge...

Read More

Resources

Events

C-Suite On Deck

Responsive image

Feature market insights and perspectives from top C-Level executives, elite technology influencers and thought leaders from your company here. This signature initiative has garnered immense support...

Contact Us